Pfizer R&D to split into large and small molecule divisions
Pfizer announced organizational plans for the company post-Wyeth acquisition, including a new focus on biopharmaceuticals, and the retention of eight ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.